Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands.

Serena Pasquini, Alessia Ligresti, Claudia Mugnaini, Teresa Semeraro, Lavinia Cicione, Maria De Rosa, Francesca Guida, Livio Luongo, Maria De Chiaro, Maria Grazia Cascio, Daniele Bolognini, Pietro Marini, Roger Guy Pertwee, Sabatino Maione, Vincenzo Di Marzo, Federico Corelli

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

A set of quinolone-3-carboxamides 2 bearing diverse substituents at position 1, 3, and 6 of the bicyclic nucleus was prepared. Except for six compounds exhibiting K-i > 100 nM, all the quinolone-3-carboxamides 2 proved to be high affinity CB2 ligands, with K-i values ranging from 73.2 to 0.7 nM and selectivity [SI = K-i(CB1)/K-i(CB2)] varying from > 14285 to 1.9, with only 2ah exhibiting a reverse selectivity (SI < 1). In the formalin test of peripheral acute and inflammatory pain in mice, 2ae showed analgesic activity that was antagonized by a selective CB2 antagonist. By contrast, 2e was inactive per se and antagonized the effect of a selective CB2 agonist. Finally, 2g and 2p exhibited CB2 inverse agonist-like behavior in this in vivo test. However, two different functional assays carried out in vitro on 2e and 2g indicated for both compounds an overall inverse agonist activity at CB2 receptors.

Original languageEnglish
Pages (from-to)5915-5928
Number of pages14
JournalJournal of Medicinal Chemistry
Volume53
Issue number16
Early online date27 Jul 2010
DOIs
Publication statusPublished - 26 Aug 2010

Keywords

  • Amides
  • Analgesics
  • Animals
  • CHO Cells
  • Cricetinae
  • Cricetulus
  • Drug Inverse Agonism
  • Humans
  • Ligands
  • Mice
  • Pain Measurement
  • Quinolones
  • Radioligand Assay
  • Receptor, Cannabinoid, CB2
  • Stereoisomerism
  • Structure-Activity Relationship

Cite this

Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands. / Pasquini, Serena; Ligresti, Alessia; Mugnaini, Claudia; Semeraro, Teresa; Cicione, Lavinia; De Rosa, Maria; Guida, Francesca; Luongo, Livio; De Chiaro, Maria; Cascio, Maria Grazia; Bolognini, Daniele; Marini, Pietro; Pertwee, Roger Guy; Maione, Sabatino; Di Marzo, Vincenzo; Corelli, Federico.

In: Journal of Medicinal Chemistry, Vol. 53, No. 16, 26.08.2010, p. 5915-5928.

Research output: Contribution to journalArticle

Pasquini, Serena ; Ligresti, Alessia ; Mugnaini, Claudia ; Semeraro, Teresa ; Cicione, Lavinia ; De Rosa, Maria ; Guida, Francesca ; Luongo, Livio ; De Chiaro, Maria ; Cascio, Maria Grazia ; Bolognini, Daniele ; Marini, Pietro ; Pertwee, Roger Guy ; Maione, Sabatino ; Di Marzo, Vincenzo ; Corelli, Federico. / Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands. In: Journal of Medicinal Chemistry. 2010 ; Vol. 53, No. 16. pp. 5915-5928.
@article{8b6afb47af6a45f4896e155ded3aae42,
title = "Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands.",
abstract = "A set of quinolone-3-carboxamides 2 bearing diverse substituents at position 1, 3, and 6 of the bicyclic nucleus was prepared. Except for six compounds exhibiting K-i > 100 nM, all the quinolone-3-carboxamides 2 proved to be high affinity CB2 ligands, with K-i values ranging from 73.2 to 0.7 nM and selectivity [SI = K-i(CB1)/K-i(CB2)] varying from > 14285 to 1.9, with only 2ah exhibiting a reverse selectivity (SI < 1). In the formalin test of peripheral acute and inflammatory pain in mice, 2ae showed analgesic activity that was antagonized by a selective CB2 antagonist. By contrast, 2e was inactive per se and antagonized the effect of a selective CB2 agonist. Finally, 2g and 2p exhibited CB2 inverse agonist-like behavior in this in vivo test. However, two different functional assays carried out in vitro on 2e and 2g indicated for both compounds an overall inverse agonist activity at CB2 receptors.",
keywords = "Amides, Analgesics, Animals, CHO Cells, Cricetinae, Cricetulus, Drug Inverse Agonism, Humans, Ligands, Mice, Pain Measurement, Quinolones, Radioligand Assay, Receptor, Cannabinoid, CB2, Stereoisomerism, Structure-Activity Relationship",
author = "Serena Pasquini and Alessia Ligresti and Claudia Mugnaini and Teresa Semeraro and Lavinia Cicione and {De Rosa}, Maria and Francesca Guida and Livio Luongo and {De Chiaro}, Maria and Cascio, {Maria Grazia} and Daniele Bolognini and Pietro Marini and Pertwee, {Roger Guy} and Sabatino Maione and {Di Marzo}, Vincenzo and Federico Corelli",
year = "2010",
month = "8",
day = "26",
doi = "10.1021/jm100123x",
language = "English",
volume = "53",
pages = "5915--5928",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "AMER CHEMICAL SOC",
number = "16",

}

TY - JOUR

T1 - Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligands.

AU - Pasquini, Serena

AU - Ligresti, Alessia

AU - Mugnaini, Claudia

AU - Semeraro, Teresa

AU - Cicione, Lavinia

AU - De Rosa, Maria

AU - Guida, Francesca

AU - Luongo, Livio

AU - De Chiaro, Maria

AU - Cascio, Maria Grazia

AU - Bolognini, Daniele

AU - Marini, Pietro

AU - Pertwee, Roger Guy

AU - Maione, Sabatino

AU - Di Marzo, Vincenzo

AU - Corelli, Federico

PY - 2010/8/26

Y1 - 2010/8/26

N2 - A set of quinolone-3-carboxamides 2 bearing diverse substituents at position 1, 3, and 6 of the bicyclic nucleus was prepared. Except for six compounds exhibiting K-i > 100 nM, all the quinolone-3-carboxamides 2 proved to be high affinity CB2 ligands, with K-i values ranging from 73.2 to 0.7 nM and selectivity [SI = K-i(CB1)/K-i(CB2)] varying from > 14285 to 1.9, with only 2ah exhibiting a reverse selectivity (SI < 1). In the formalin test of peripheral acute and inflammatory pain in mice, 2ae showed analgesic activity that was antagonized by a selective CB2 antagonist. By contrast, 2e was inactive per se and antagonized the effect of a selective CB2 agonist. Finally, 2g and 2p exhibited CB2 inverse agonist-like behavior in this in vivo test. However, two different functional assays carried out in vitro on 2e and 2g indicated for both compounds an overall inverse agonist activity at CB2 receptors.

AB - A set of quinolone-3-carboxamides 2 bearing diverse substituents at position 1, 3, and 6 of the bicyclic nucleus was prepared. Except for six compounds exhibiting K-i > 100 nM, all the quinolone-3-carboxamides 2 proved to be high affinity CB2 ligands, with K-i values ranging from 73.2 to 0.7 nM and selectivity [SI = K-i(CB1)/K-i(CB2)] varying from > 14285 to 1.9, with only 2ah exhibiting a reverse selectivity (SI < 1). In the formalin test of peripheral acute and inflammatory pain in mice, 2ae showed analgesic activity that was antagonized by a selective CB2 antagonist. By contrast, 2e was inactive per se and antagonized the effect of a selective CB2 agonist. Finally, 2g and 2p exhibited CB2 inverse agonist-like behavior in this in vivo test. However, two different functional assays carried out in vitro on 2e and 2g indicated for both compounds an overall inverse agonist activity at CB2 receptors.

KW - Amides

KW - Analgesics

KW - Animals

KW - CHO Cells

KW - Cricetinae

KW - Cricetulus

KW - Drug Inverse Agonism

KW - Humans

KW - Ligands

KW - Mice

KW - Pain Measurement

KW - Quinolones

KW - Radioligand Assay

KW - Receptor, Cannabinoid, CB2

KW - Stereoisomerism

KW - Structure-Activity Relationship

U2 - 10.1021/jm100123x

DO - 10.1021/jm100123x

M3 - Article

VL - 53

SP - 5915

EP - 5928

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 16

ER -